Progenics other research news

PGNX received a 2-year $600,000 Phase I SBIR grant from

Read the full 106 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE